This Week in Psychedelics - 11.20.20

Cannabis

• Mexican Senate Passes Bill To Legalize Marijuana Nationwide (Marijuana Moment)

• Israel Announced Intentions To Legalize Recreational Cannabis (High Times)

• Argentina redraws medical cannabis rules, allowing home cultivation (Marijuana Business Daily)

• Cannabis resin now 25% more potent, global study reveals (The Guardian)

• New Jersey Senate Approves Marijuana Decriminalization Despite Contentious Psychedelics Provision (Marijuana Moment)

• CBD is not a narcotic, says EU court as it rules French ban is illegal (The Guardian)

• Lawmakers In Wisconsin Capital Vote To Allow Marijuana Use In Public (Marijuana Moment)

• How marijuana legalization made strides across the US in this election (The Guardian)

• New Jersey Senate And Assembly Committee Pass Marijuana Sales Bills Despite Pushback From Equity Advocates (Marijuana Moment)

• New Jersey: Senate Lawmakers Approve Legislation to End Low-Level Marijuana Arrests (NORML)

LSD

• Joanna Harcourt-Smith, Lover of Timothy Leary, High Priest of LSD, Dies at 74 (The New York Times)

• MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities (Psilocybin Alpha)

• Florida man on LSD tackles Disney security guard at Animal Kingdom (Orlando Weekly)

Magic Mushrooms

• First Non-Palliative Canadian Granted Access To Psilocybin Therapy (Psilocybin Alpha)

• Usona Offers Psilocybin to Eligible Researchers at No Cost (Usona Institute)

• Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics (Psilocybin Alpha)

• Psilocybin increases the expression neuroplasticity-related genes in rats (PsyPost)

• Psilocybin for Depression Study Approved and Funded by German Government (Psilocybin Alpha)

• Pilot Study of Psilocybin-Assisted Group Therapy in Older AIDS Survivors (Psychedelic Science Review)

• Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks (Psilocybin Alpha)

• Aeruginascin Identified in Psilocybe cubensis Magic Mushrooms (Psychedelic Science Review)

• NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss (Psilocybin Alpha)

• How will Oregon’s new psilocybin therapy program work? (OPB)

• Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders (Psilocybin Alpha)

• ACT and PcbAP for Depression – A Natural Synergy Part 2: The Technical Integration (Psychedelic Science Review)

• Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program (Psilocybin Alpha)

Ketamine

• Happiness during ketamine infusion predicts treatment-resistant depression outcomes (Healio)

• Ketamine May Be Helpful in Treating Alcohol Use Disorder (Psychology Today)

• Veterans Are Using Ketamine-Assisted Psychotherapy To Help With PTSD (Green Entrepreneur)

Miscellaneous

• Vancouver proposes decriminalizing possession of small amounts of drugs (The Globe and Mail)

• Canadian Officials Respond To Psychedelics Decriminalization Petition, Saying No Legal Changes Needed (Marijuana Moment)

• UK on the Brink of a Psychedelic Therapy Revolution (Filter)

• One Simple Way Biden Could Prove He Regrets His Role in the Drug War (Slate)

• How Tripping Can Help Us Reimagine Capitalism Ahead of Psychedelic Commercialization (DoubleBlind)

• High Country: The Aspen Brain Institute examines the promising future of psychedelic-assisted therapy (The Aspen Times)

• The Oregon Model (The Baffler)

• Keys for Integrating Psychedelic Experiences (Psychedelics Today)

• Kin Spruijt: A Psychedelic Nurse in a Dutch Psychiatric Clinic (Chacruna)

• Paraphernalia Decrim Advances in DC—Just Not for Drug Sellers (Filter)

• Breaking Barriers So Psychedelic Experiences Can Become Mainstream (Forbes)

• What is the Default Mode Network? (Psychedelic Science Review)

• Avoiding Negative Experiences With Microdosing (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.13.20

Cannabis

• House will vote on cannabis legalization bill in December (Politico)

• Mexican Senators Will Vote On Revised Marijuana Legalization Bill This Week (Marijuana Moment)

• Can Marijuana Help Biden Heal a Divided Nation? (Bloomberg)

• Marijuana Reform Omitted From Biden Transition Plan On Racial Equity Despite Campaign Pledges (Marijuana Moment)

• Gallup: Record Percentage of Americans Say “Marijuana Should Be Made Legal” (NORML)

• New Jersey Committees Cancel Marijuana Sales Bill Votes Amid Disputes Over Provisions (Marijuana Moment)

• Virginia: Legislation Barring Police from Using Marijuana Odor to Stop or Search Takes Effect Early 2021 (NORML)

• Texas Lawmakers Pre-File Marijuana Bills For 2021 Session (Marijuana Moment)

• People around the country keep voting for marijuana. Here's why that's unlikely in NC. (The News & Observer)

• Montana Marijuana Opponents File New Lawsuit To Overturn Legalization Vote (Marijuana Moment)

• Cannabis May Have Negative Effects On Sperm, Review Finds (Benzinga)

• Marijuana Regulators From 19 States Form Group To Coordinate Legalization Implementation (Marijuana Moment)

• After heart attack, pot smoking raises post-op dangers (Medical Xpress)

LSD

• Free Love and LSD: Photos of Life in a 70s Commune (VICE)

Magic Mushrooms

• Bill to decriminalize marijuana in N.J. passes in committee — and is amended to include hallucinogenic mushrooms (The Philadelphia Inquirer)

• Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin (Psilocybin Alpha)

• Niños Santos, Psilocybin Mushrooms and the Psychedelic Renaissance (Chacruna)

• NeonMind Obtains Health Canada Approval to Advance Psilocybin Research (Psilocybin Alpha)

MDMA

• MDMA does not increase trust or cause a hangover, study says (New York Post)

DMT

• Meet the Man Who Brought DMT to the Masses (VICE)

Ayahuasca

• The Ayahuasca Afterglow Phenomenon: Exploring Its Significance and Limitations (Psychedelic Science Review)

• Jordi Riba and the Challenges of Studying Ayahuasca (Psychedelic Science Review)

Ketamine

• New Program Brings Ketamine-Assisted Psychotherapy to Canadian Vets (Lucid News)

• Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon (Psilocybin Alpha)

• Microscopes, Telescopes, and Ketamine (The Third Wave)

Miscellaneous

• California Could Decriminalize Psychedelics Under New State And Local Proposals (Marijuana Moment)

• What happens when psychedelics make you see God (Popular Science)

• Psychedelics Won the Election—Except the Psychedelic that is Donald Trump (DoubleBlind)

• Can Microdosing Make You a Better Athlete? (Playboy)

• DEA Pursues Vast Expansion of Patient Surveillance (Filter)

• The Cost of Exclusion in Psychedelic Research (Bill of Health)

• Here’s why Black people in the UK are turning to psychedelics (gal-dem)

• Psychedelic Scientists Should Honor Indigenous Plants and Traditions (Chacruna)

• Europe's Teenage Drug Use Hotspots Revealed By New Study (VICE)

• A Handful of Start-Ups Is Developing Psychedelic Drugs for Mental Illnesses. It Could Be a Bad Trip for Investors. (Barron's)

• Banned Lecture of Getting Higher (Psychedelic Press UK)

• The Cost of Omission: Dr. Valentina Wasson and Getting Our Stories Right (Chacruna)

• Cybin Goes Public on the NEO Exchange Under Symbol CYBN (Psilocybin Alpha)

• Silo Pharma, Inc. Launches Scientific Advisory Board with Appointment of Dr. Matthew Johnson of John Hopkins University (Psilocybin Alpha)

• Can Psychedelics Treat Eating Disorders? (DoubleBlind)

• Growing Up with Sacred Plants (Chacruna)

• Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.6.20

Cannabis

• Voters Approve All Seven Marijuana-Legalization Initiatives Across Five States (Filter)

• New Zealand Voters Narrowly Reject Nationwide Marijuana Referendum In Final Vote Tally (Marijuana Moment)

• Four More Ohio Cities Approve Marijuana Decriminalization Measures (Marijuana Moment)

• 2020 Ballot Initiative Effective Dates (NORML)

• Texas Sees Its First Hemp Harvest in 80 Years (The Austin Chronicle)

• Clinical Trial: Plant-Derived Cannabis Oil Effective for Patients with Fibromyalgia (NORML)

LSD

• MindMed Completes Phase 1 LSD Dosing Study (Psilocybin Alpha)

Magic Mushrooms

• Oregon Legalizes Psilocybin Therapy (DoubleBlind)

• Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Shows (Johns Hopkins Medicine)

• Havn Life Sciences to Support the First Modern Psilocybin Depression Study in Germany with Mind Foundation (Psilocybin Alpha)

DMT

• Do Orgasms Cause the Release of DMT? (DoubleBlind)

Ayahuasca

• COVID and the Future of Ayahuasca in Brazil (Chacruna)

• The Colonization of the Ayahuasca Experience (JSTOR Daily)

Mescaline

• Heroines of Mescaline (Chacruna)

Peyote

• Why Matthew McConaughey Spent Hours In A Cage With A Mountain Lion (TheThings)

Ketamine

• People Are Using Ketamine at Home to Escape Their Pandemic Reality (VICE)

• Use of Acute and Maintenance Intravenous Ketamine in Outpatients With Depression (Psychiatry Advisor)

Miscellaneous

• Every Single Marijuana And Drug Policy Ballot Measure Passing On Election Day Bolsters Federal Reform Push (Marijuana Moment)

• Oregon becomes 1st state in the US to decriminalize drug possession (OPB)

• DC voters approve decriminalizing ‘magic mushrooms,’ other psychedelics (Fox 5)

• There's No Good Evidence that Psychedelics Can Change Your Politics or Religion (Scientific American)

• From Mining to Mushrooms (Psymposia)

• Improved colour blindness symptoms associated with recreational psychedelic use (Drug Science)

• Biden Says Anti-Drug Policies Harmed Black Communities, And It Was A ‘Mistake’ To Support Them (Marijuana Moment)

• Hate & Social Media in Psychedelic Spaces (Chacruna)

• Empowering Queer, LGBTQ, and Two-Spirit Voices in Psychedelics with Marca Cassity (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.30.20

Cannabis

• New Zealand Marijuana Legalization Trails In Early Referendum Results, But More Votes To Be Counted (Marijuana Moment)

• New Jersey Lawmakers Approve Bill Providing Medical Marijuana Patient Insurance Benefits (Marijuana Moment)

• Study: Seniors Report Using Cannabis Products to Mitigate Symptoms Associated with Older Age (NORML)

• Mississippi Supreme Court Won’t Consider Challenge To Medical Marijuana Measure Until After Election (Marijuana Moment)

• South Dakota: Oglala Sioux Enacts Ordinance Legalizing Marijuana Use on Tribal Lands (NORML)

• New Jersey Marijuana Sales Could Start Just Weeks After Election Day Under Key Senator’s Plan (Marijuana Moment)

• Study suggests that cannabis can reduce OCD symptoms by half in short term (Hindustan Times)

• Idaho Activists Submit 2022 Medical Marijuana Initiative Following 2020 Complications (Marijuana Moment)

• Schools And NCAA Could Ban Marijuana Sponsorships Under Bill To Let Student Athletes Monetize Their Success (Marijuana Moment)

• Virginia NORML Calls for Legalization to Protect Marijuana Consumers from Potentially Tainted Products (NORML)

• South Dakota Voters Back Marijuana Legalization And Medical Cannabis Ballot Measures, Poll Finds (Marijuana Moment)

• The Music Never Stops With Jerry Garcia’s Just-Launched Cannabis Collection (Forbes)

LSD

• Killer High: Exploring the Phenomenon of LSD-Fuelled Murder (VICE)

• The psychedelics revolution has arrived in New Zealand (The Spinoff)

Magic Mushrooms

• Covid Can't Kill Mushrooms: The coronavirus has infected, but not killed, the movement to bring magic mushrooms to the masses (Rooster Magazine)

• Expanding On Psilocybin Research, John Hopkins Hoping To Hear From More Users (CBS Baltimore)

MDMA

• ‘Sorted’ for Es? Women and Ecstasy in 1990s Britain (Chacruna)

DMT

• SLU professor is authority on drug that landed him in jail (WWNY-TV)

Ayahuasca

• Ayahuasca Ceremonies and Tourism Return to Costa Rica (The Costa Rica Star)

• Studies lift the veil on psychedelic brew ayahuasca, its mental health benefits and potential to treat depression and trauma (South China Morning Post)

• Documentary looks at mystery medicine, Ayahuasca (The Leaf Online)

Mescaline

• What Is Mescaline? A Guide to this Cactus-Derived Psychedelic (DoubleBlind)

Synthetic Cannabinoids

• Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD (Marijuana Business Daily)

• Synthetic Cannabis Could Disrupt The Marijuana Industry In A Big Way (Green Entrepreneur)

Ketamine

• Wearable Ketamine Delivery Device Developed As Alternative to Opioid-Based Pain Management (Lucid News)

• Ketamine Helps People Dislike Themselves Less (Psychedelic Science Review)

• Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain (Psilocybin Alpha)

• Can Dissociative Side Effect of “Floating” Predict Response to Ketamine in MDD? (Psychiatry Advisor)

Miscellaneous

• No Drugs Should Be Criminalized. It’s Time to Abolish the DEA. (Truthout)

• ‘Drug Free USA Forever’ Stamps Launched By DEA, Postal Service And Miss America (Marijuana Moment)

• Inside the ‘Psychedelic Exceptionalism’ Debate: Should All Drugs be Legal, or Just Pot and Psychedelics? (DoubleBlind)

• Psilocybin Group Therapy Improves Demoralization for AIDS Survivors (Chacruna)

• Children and Psychedelics: Re-examining Cultural Paradigms (Psychedelics Today)

• International study finds 79% of individuals who microdose with psychedelics report improvements in their mental health (PsyPost)

• Ketamine Meditation, Jungle Tripping and Modern-Day Shamans: Meet a ‘Psychedelic Concierge’ (VICE)

• The Role of Psychedelic Plant Medicines in Addiction Treatment (The Fix)

• A Collective Call for Accountability in Plant Medicine Experiences (Chacruna)

• Who owns psychedelics: patents and state therapeutic access laws (New Amsterdam Psychedelic Law)

• Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development (Psilocybin Alpha)

• What do Santo Daime and Raves Have in, Common? The Answer Might Move You (Chacruna)

• Journey Colab bags $3M from 'moonshot' fund to push new development model for psychedelic treatments (Fierce Biotech)

• Where Witchcraft Meets Plant Medicine (DoubleBlind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.23.20

Cannabis

• Virginia: Medical Cannabis Dispensing Begins (NORML)

• Missouri medical marijuana dispensaries open to long lines, happy patients (Leafly)

• Montana Supreme Court Rejects Challenge To Marijuana Legalization Initiative (Marijuana Moment)

• USDA Approves Hemp Plans For Six Additional States And Three Indian Tribes (Marijuana Moment)

• Virginia Bill To Ban Police Searches Based On Marijuana Smell Gets Governor-Suggested Changes (Marijuana Moment)

• Pennsylvania House Votes To Protect Medical Marijuana Patients From DUI Charges (Marijuana Moment)

LSD

• LSD: new scientific study shows microdosing elevates mood and cognition (Boing Boing)

• ‘My Psychedelic Love Story’ Review: Errol Morris’ Touching LSD Romance Adds New Dimension to Timothy Leary (IndieWire)

• Could Giving Acid to Dolphins Help Us Talk to Aliens? (DoubleBlind)

• Bill Wilson, LSD and the Secret Psychedelic History of Alcoholics Anonymous (Lucid News)

Magic Mushrooms

• First Psilocybin for Depression Clinical Trial Launched in Sweden (Psilocybin Alpha)

• Phase 2 Clinical Trial to Evaluate Safety and Efficacy of Psilocybin in Cancer Patients with Major Depressive Disorder (Psilocybin Alpha)

• Psilocybin and Mindfulness for Depression: Complementary Actions Starting to Emerge (Psychedelic Science Review)

• Pharmaceutical Startup Developing Sublingual Psilocybin Raises $34 Million To Fund Clinical Trials (Forbes)

• Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms (Psilocybin Alpha)

• Allied Expands Pharmaceutical Pipeline By Filing US Provisional Patent for Psilocybin Based Therapeutics (GlobeNewswire)

MDMA

• Government urged to sell cocaine and ecstasy in pharmacies (The Guardian)

Ayahuasca

• Ayahuasca, Capitalism and the New Age (Chacruna)

Peyote

• What Groups Are Doing to Protect Against Peyote Poaching (Green Entrepreneur)

Ketamine

• Ketamine-Induced Brain Rhythm Causes Dissociation: From Mice to Man (Psychedelic Science Review)

• Pharmather to Advance Ketamine as Potential Dyskinesia Treatment (Parkinson's News Today)

Miscellaneous

• Early Christians Might Have Been High on Hallucinogenic Communion Wine (VICE)

• People who microdose psychedelic drugs report that the benefits greatly outweigh the drawbacks (PsyPost)

• DEA recruits cite ‘monkey noises’ among claims of racism (Associated Press)

• Scientists identify a powerful anti-inflammatory compound in psychedelic drugs (Massive Science)

• Watch The Oregon Drug Decriminalization Campaign’s New TV Ads For Historic Ballot Measure (Marijuana Moment)

• 2020’s psychedelic drug ballot measures, explained (Vox)

• An Open Letter and Call to Action for MAPS Canada (Psymposia)

• Media Company Delic Corp. Announces RTO, Becomes Latest Psychedelics Company Planning to Go Public (Psilocybin Alpha)

• Jedi Flipping: What It’s Like to Mix Shrooms, Acid, and Molly (DoubleBlind)

• How to Talk to Your Therapist About Psychedelics (Psychology Today)

• “Psychedelics are Not Cotton Candy and Rainbows” with Sensei Kevon Simpson (Chacruna)

• Psyched Wellness Becomes Latest Psychedelics Company to Go Public (CSE: PSYC) (Psilocybin Alpha)

• Examining the Effects of Psychedelics on Experiential Avoidance (Psychedelic Science Review)

• Nina Graboi, A Forgotten Woman in Psychedelic Lore (Chacruna)

• Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds (Psilocybin Alpha)

• 6 Herbs to Enhance Your Next Psychedelic Trip (DoubleBlind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.